A board-certified ophthalmologist with more than 35 years of clinical, academic, and forensic experience specializes in corneal disease, corneal transplantation, cataract surgery, dry eye disease, glaucoma, uveitis, ocular infections, and intraocular lenses. He has over 25 years of expert witness experience involving consultations, depositions, and courtroom testimony in matters related to ophthalmic standards of care, ocular therapeutics, surgical outcomes, vision loss, inflammatory eye disease, and ophthalmic pharmaceuticals. His work also includes extensive involvement in ocular pharmacology, FDA clinical research, and development of ophthalmic drugs and devices, having served as principal investigator in more than 110 clinical trials involving dry eye disease, uveitis, glaucoma, cataract surgery, corneal disorders, and ocular inflammation.

In addition to serving as President and Senior Managing Partner of a multi-specialty ophthalmology practice, he holds leadership roles in ophthalmic research and medical education, including positions as Clinical Director of an ocular pharmacology research center and Professor of Ophthalmology, Microbiology, and Molecular Biology. He has authored more than 110 peer-reviewed publications and textbook chapters and has delivered hundreds of invited lectures nationally and internationally on ocular surface disease, corneal transplantation, dry eye management, cataract surgery, glaucoma, ocular inflammation, and ophthalmic therapeutics. His professional distinctions include board certification in ophthalmology, Fellow status with the American College of Surgeons (F.A.C.S.), service as a Mentor Examiner for the American Board of Ophthalmology, and recognition by the American Academy of Ophthalmology with its Senior Honor Award.